Emerade Adrenaline (epinephrine) Auto-injector

Emerade is a specialized medical device used for the emergency treatment of severe acute allergic reactions (anaphylaxis). The brand was developed to provide a reliable delivery system for adrenaline (epinephrine). The product is notably associated with European healthcare markets and is designed to be intuitive for use in life-threatening situations.

The global rights and manufacturing of Emerade are held by Pharma-Data S.A., though it has historically been distributed by various regional partners such as Bausch + Lomb in the UK and Ireland. Production typically occurs in high-standard pharmaceutical facilities in Sweden and other European locations to ensure strict adherence to safety and quality protocols required for injectable medications. While ownership remains with Pharma-Data, the brand is prominent in international markets through specific licensing and distribution agreements.